Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on 02/15/2023. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-687-05
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)
- Initial Posting
- 02/15/2023
- Revised Date
Reason
Shortage of an active ingredient